FDA Approved: TRAVOPROST OPHTHALMIC SOLUTION, 0.004% — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for travoprost ophthalmic solution 0.004% by Mylan Pharmaceuticals, expanding access to a generic prostaglandin analogue…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• TRAVOPROST OPHTHALMIC SOLUTION, 0.004% (travoprost ophthalmic solution 0.004%)

Snippet

SUPPL AP for TRAVOPROST OPHTHALMIC SOLUTION, 0.004% (TRAVOPROST OPHTHALMIC SOLUTION, 0.004%)